tiprankstipranks
Trending News
More News >
CARsgen Therapeutics Holdings Ltd. (HK:2171)
:2171

Compare CARsgen Therapeutics Holdings Ltd. (2171) vs. Competitors

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$9.52B
-16.56
75.48%
Ascletis Pharma, Inc.
HK$12.33
HK$12.49B
-44.18
311.44%
1 Buy
1 Hold
0 Sell
Moderate Buy
Everest Medicines Ltd.
HK$51.50
HK$13.85B
-17.86
-10.18%
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$9.91B
-47.34
123.11%
1 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$14.25B
99.64
381.23%
Shanghai Haohai Biological Technology Co., Ltd. Class H
HK$24.90
HK$10.95B
14.18
2.72%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2171
CARsgen Therapeutics Holdings Ltd.
16.46
6.86
71.46%
HK:1672
Ascletis Pharma, Inc.
12.59
9.41
295.91%
HK:1952
Everest Medicines Ltd.
39.16
-0.29
-0.74%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.33
3.06
134.80%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
35.90
28.21
366.84%
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
25.68
2.56
11.07%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts